Anesthetic Considerations for Geriatric Surgery

  • Stephen N. Harris

Abstract

Is a healthy geriatric patient different from a healthy 20-year-old? If so, how should one approach the elderly from an anesthetic standpoint when assessing them prior to surgery? Are there some basic differences that affect anesthetic management? Understanding the physiologic and pharmacologic changes associated with aging give us insight to help discern the effects of aging and the consequences of age-related disease. Other chapters of this book cover preoperative risk assessment and specific organ systems in great detail; this chapter addresses the geriatric patient from the anesthesiologist’s viewpoint. Pertinent organ systems are taken into consideration in terms of their impact on the perioperative anesthetic plan. In addition, recommendations concerning perioperative care of the geriatric patient focus on how commonly used anesthetics, techniques, and management affect the perioperative care of the geriatric patient.

Keywords

Elderly Patient Cardiac Output Central Venous Pressure Histamine Release Geriatric Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation and allostatic load and its health conse- quences: MacArthur studies of successful aging. Arch Intern Med 1997;157:2259–2268.PubMedCrossRefGoogle Scholar
  2. 2.
    McLeskey CH. Anesthesia for the geriatric patient. In: Barash P, Cullen B, Stoelting R (eds) Clinical Anesthesia, 2nd ed. Philadelphia: Lippincott, 1992.Google Scholar
  3. 3.
    Rakowski W, Hickey T. Mortality and the attribution of health problems to aging among older adults. Am J Public Health 1992;82:1139–1141.PubMedCrossRefGoogle Scholar
  4. 4.
    Fleisher LA. Preoperative evaluation. In: Barash P, Cullen B, Stoelting R (eds) Clinical Anesthesia, 3rd ed. Philadelphia: Lippincott, 1997.Google Scholar
  5. 5.
    American Society of Anesthesiologists. The ASA Directory of Members 1994. Park Ridge, IL: American Society of Anesthesiologists, 1994.Google Scholar
  6. 6.
    Roizen MF. Preoperative evaluation. In: Miller RD (ed) Anesthesia. New York: Churchill Livingstone, 1994:827.Google Scholar
  7. 7.
    Goldman L, Caldera DL, Nussbaum STR, et al. Multifactorial index of cardiac risk in non-cardiac surgical procedures. N Engl J Med 1997;297:845.CrossRefGoogle Scholar
  8. 8.
    Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153–184.PubMedCrossRefGoogle Scholar
  9. 9.
    Vacanti CJ, Van Houten RJ, Hill RC. A statistical analysis of the relationship of physical status to postoperative mortality in 68,388 cases. Anesth Analg 1970;49:564.PubMedCrossRefGoogle Scholar
  10. 10.
    Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978;49:239.PubMedCrossRefGoogle Scholar
  11. 11.
    Grenburg AG, Saik RP, Pridham D. Influence of age on mortality of colon surgery Am J Surg 1985;150:65–70.Google Scholar
  12. 12.
    Muravchick S. Geroanesthesia: Principles for Management of the Elderly Patient. St. Louis: Mosby, 1997.Google Scholar
  13. 13.
    Tiret L, Desmonts JM, Hatton F, et al. Complications associated with anaesthesia: a prospective survey in France. Can Anaesth Soc J 1986;33:336.PubMedCrossRefGoogle Scholar
  14. 14.
    Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261.PubMedCrossRefGoogle Scholar
  15. 15.
    Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations. Part 2. Clin Pharmacokinet 1991;21:262–273.PubMedCrossRefGoogle Scholar
  16. 16.
    Sladen R, Prough D. Perioperative renal protection. Probl Anesth 1997;9:314–331.Google Scholar
  17. 17.
    Hypothermia related deaths—Georgia, January 1996-December 1997, and United States, 1979–1995. MMWR 1999;47(48):1037–1041.Google Scholar
  18. 18.
    Matsukawa T, Sessler D, Sessler A, et al. Heat flow and distribution during induction of general anesthesia. Anesthesiology 1995;82:662–673.PubMedCrossRefGoogle Scholar
  19. 19.
    Frank SM, Beattie C, Christopherson R, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia: the perioperative ischemia randomized anesthesia trial study group. Anesthesiology 1993;78:468–476.PubMedCrossRefGoogle Scholar
  20. 20.
    Frank SM, Shir Y, Raja SN, Fleisher LA, Beattie C. Core hypothermia and skin surface temperature gradients, epidural versus general anesthesia and the effects of age. Anesthesiology 1994;80:502–508.PubMedCrossRefGoogle Scholar
  21. 21.
    Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events: a randomized clinical trial. JAMA 1997;277:1127–1134.PubMedCrossRefGoogle Scholar
  22. 22.
    Beilin B, Shavit Y, Razumovsky J, Wolloch Y, Zeidel A, Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 1998;89:1133–1140.PubMedCrossRefGoogle Scholar
  23. 23.
    Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199–209.PubMedCrossRefGoogle Scholar
  24. 24.
    Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996;334:1209–1215.PubMedCrossRefGoogle Scholar
  25. 25.
    Just B, Trevien V, Delva E, Lienhardt A. Prevention of intraoperative hypothermia by preoperative skin-surface warming. Anesthesiology 1993;79:214–218.PubMedCrossRefGoogle Scholar
  26. 26.
    Hynson J, Sessler D. Intraoperative warming therapies: a comparison of three devices. J Clin Anesth 1992;4:194–199.PubMedCrossRefGoogle Scholar
  27. 27.
    Lakatta EG. Aging effects on the vasculature in health: risk factors for cardiovascular disease. Am J Geriatr Cardiol 1994;6:11–17.Google Scholar
  28. 28.
    Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413–467.PubMedGoogle Scholar
  29. 29.
    Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine, 5th ed. Philadelphia: Saunders, 1997.Google Scholar
  30. 30.
    Cahalan MK, Hashimoto Y, Aizawa K, et al. Elderly, conscious patients have an accentuated hypotensive response to nitroglycerin. Anesthesiology 1992;77:646–655.PubMedCrossRefGoogle Scholar
  31. 31.
    Wood M, Hyman S, Wood AJ. A clinical study of sensitivity to sodium nitroprusside during controlled hypotensive anesthesia in young and elderly patients. Anesth Analg 1987;66:132–136.PubMedCrossRefGoogle Scholar
  32. 32.
    Harris SN, Ballantyne GH, Luther MA, Perrino AC Jr. Alterations of cardiovascular performance during laparoscopic colectomy: a combined hemodynamic and echocardio-graphic analysis. Anesth Analg 1996;83:482–487.PubMedGoogle Scholar
  33. 33.
    Perrino AC Jr. Cardiac output monitoring by echocardiography: should we pass on Swan-Ganz catheters? Yale J Biol Med 1993;66:397–413.PubMedGoogle Scholar
  34. 34.
    Perrino AC Jr, Harris SN, Luther MA. Intraoperative determination of cardiac output using multiplane transesophageal echocardiography: a comparison to thermodilution. Anesthesiology 1998;89:350–357.PubMedCrossRefGoogle Scholar
  35. 35.
    Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta stone. J Am Coll Cardiol 1997; 30:8–18.PubMedCrossRefGoogle Scholar
  36. 36.
    Frishman WH, Furberg CD, Friedwald WT. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med 1984;310:830–837.PubMedCrossRefGoogle Scholar
  37. 37.
    First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57–66.Google Scholar
  38. 38.
    Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life, The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762–768.PubMedCrossRefGoogle Scholar
  39. 39.
    Cleland J, Bristow M, Erdman E, Remmes W, Swedberg K, Waagstein F. Beta blocking agents in heart failure. Eur Heart J 1996;17:1629–1639.PubMedCrossRefGoogle Scholar
  40. 40.
    Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk in non cardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 1997;96:1882–1887.PubMedCrossRefGoogle Scholar
  41. 41.
    Fleisher LA, Eagle KA. Screening non cardiac surgery patients for cardiac disease. Ann Intern Med 1996;124:767–772.PubMedCrossRefGoogle Scholar
  42. 42.
    Fleisher LA, Nelson AH, Rosenbaum SH. Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease? J Clin Anesth 1995;7:97–102.PubMedCrossRefGoogle Scholar
  43. 43.
    Wallace A, Layug E, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998;88:7–17.PubMedCrossRefGoogle Scholar
  44. 44.
    Mangano D, Layug E, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713–1720.PubMedCrossRefGoogle Scholar
  45. 45.
    Waltier D. ß-Adrenergic blocking drugs: incredibly useful, incredibly underutilized. Anesthesiology 1998;88:2–5.CrossRefGoogle Scholar
  46. 46.
    Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly. Clin Pharmacokinet 1998;35:49–64.PubMedCrossRefGoogle Scholar
  47. 47.
    Stevens WC, Kingston HG. Inhalational anesthesia. In: Barash P, Cullen B, Stoelting R (eds) Clinical Anesthesia, 3rd ed. Philadelphia: Lippincott, 1997.Google Scholar
  48. 48.
    Strum D, Eger EI II, Unadakat J, Johnson B, Carpenter R. Age affects the pharmacokinetics of inhaled anesthetics in humans. Anesth Analg 1991;73:310–318.PubMedCrossRefGoogle Scholar
  49. 49.
    Helman JD, Leung J, Bellows W, et al. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. Anesthesiology 1992;77:47–62.PubMedCrossRefGoogle Scholar
  50. 50.
    Ebert TJ, Kharasch ED, Rooke GA, Shroff A, Muzi M. Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevo-flurane and isoflurane. Anesth Analg 1997;85:993–999.PubMedGoogle Scholar
  51. 51.
    Kharasch ED, Frink EJ Jr, Zager R, Bowdle TA, Artu A, Nogami WM. Assessment of low flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86:1238–1253.PubMedCrossRefGoogle Scholar
  52. 52.
    Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997;86:1231–1237.PubMedCrossRefGoogle Scholar
  53. 53.
    Dexter F, Tinker JH. Comparisons between desflurane and isoflurane or propofol on time to following commands and time to discharge: a metaanalysis. Anesthesiology 1995;83: 77–82.PubMedCrossRefGoogle Scholar
  54. 54.
    Juvin P, Servin F, Giraud O, Desmonts JM. Emergence of elderly patients from prolonged desflurane, isoflurane, or propofol anesthesia. Anesth Analg 1997;85:647–651.PubMedGoogle Scholar
  55. 55.
    Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 1988:60:146–150.PubMedCrossRefGoogle Scholar
  56. 56.
    Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88:1170–1182.PubMedCrossRefGoogle Scholar
  57. 57.
    Zamacora MK, Suarez E, Aguilera L, Rodriguez-Sasiann, Aguirre C, Calvo R. Serum protein binding of propofol in critically ill patients. Acta Anaesthesiol Scand 1997;41:1267–1272.CrossRefGoogle Scholar
  58. 58.
    Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90:1502–1516.PubMedCrossRefGoogle Scholar
  59. 59.
    Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Part 1. Clin Pharmacokinet 1991;21:165–177.PubMedCrossRefGoogle Scholar
  60. 60.
    Jacobs JR, Reves JG, Marty J, White WD, Bai SA, Smith LR. Aging increases the pharmacodynamic sensitivity to the hypnotic effects of midazolam. Anesth Analg 1995;80:143–148.PubMedGoogle Scholar
  61. 61.
    Albrecht S, Ihmsen H, Hering W, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther 1999;65:630–639.PubMedCrossRefGoogle Scholar
  62. 62.
    Singleton MA, Rosen JI, Fisher DM. Pharmacokinetics of fentanyl in the elderly. Br J Anaesth 1988;60:619–622.PubMedCrossRefGoogle Scholar
  63. 63.
    Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991;74: 34–42.PubMedCrossRefGoogle Scholar
  64. 64.
    Helmers JH, van Leeuwen L, Zuurmond WW. Sufentanil pharmacokinetics in young and elderly surgical patients. Eur J Anaesthesiol 1994;11:181–185.PubMedGoogle Scholar
  65. 65.
    Matteo RS, Schwartz AE, Ornstein E, Young WL, Chang WJ. Pharmacokinetics of sufentanil in the elderly surgical patient. Can J Anaesth 1990;37:852–856.PubMedCrossRefGoogle Scholar
  66. 66.
    Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short acting, mu-opioid. Anesth Analg 1996;83:646–651.PubMedGoogle Scholar
  67. 67.
    Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997;86:10–23.PubMedCrossRefGoogle Scholar
  68. 68.
    Jhaveri R, Joshi P, Batenhorst R, Baughman V, Glass PS. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology 1997;87:253–259.PubMedCrossRefGoogle Scholar
  69. 69.
    Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997;86:24–33.PubMedCrossRefGoogle Scholar
  70. 70.
    Bevan David R, Donati F. Muscle relaxants. In: Barash P, Cullen B, Stoelting R (eds) Clinical Anesthesia, 3rd ed. Philadelphia: Lippincott, 1997.Google Scholar
  71. 71.
    Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology 1990;72:272–275.PubMedCrossRefGoogle Scholar
  72. 72.
    Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Diaz J, Wolf KB. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996;84:520–525.PubMedCrossRefGoogle Scholar
  73. 73.
    Sorooshian SS, Stafford MA, Eastwood NB, Boyd AH, Hull CJ, Wright PM. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996;84:1083–1091.PubMedCrossRefGoogle Scholar
  74. 74.
    Vanlinthout LE, van Egmond J, de Boo T, Lerou JG, Wevers RA, Booij LH. Factors affecting magnitude and time course of neuromuscular block produced by suxamethonium. Br J Anaesth 1992;69:29–35.PubMedCrossRefGoogle Scholar
  75. 75.
    Koscielniak-Nelson Z, Bevan J, Baxter M, Donati F, Bevan D. Onset of maximum neuromuscular block following suc-cinylcholine or vecuronium in four age groups. Anesthesiology 1993;79:229–234.CrossRefGoogle Scholar
  76. 76.
    Rupp SM, Castagnoli KP, Fisher DM, Miller RD. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly patients. Anesthesiology 1987;67:45–49.PubMedCrossRefGoogle Scholar
  77. 77.
    Lien CA, Matteo RS, Ornstein E, Schwartz AE, Diaz J. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991;73:39–42.PubMedCrossRefGoogle Scholar
  78. 78.
    Bevan DR, Fiset P, Balendran P, Law-Min JC, Ratcliffe S, Donati F. Pharmacodynamic behavior of rocuronium in the elderly. Can J Anaesth 1993;40:127–132.PubMedCrossRefGoogle Scholar
  79. 79.
    Maddineni VR, Mirakhur RK, McCoy EP, Sharpe TD. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth 1994;73:608–612.PubMedCrossRefGoogle Scholar
  80. 80.
    Atherton DP, Hunter JM. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clin Pharmacokinet 1999;36:169–189.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Stephen N. Harris

There are no affiliations available

Personalised recommendations